Efficacy and safety of memantine in children with autism spectrum disorder: Results from three phase 2 multicenter studies

Three phase 2 trials were conducted to assess the efficacy and long-term safety of weight-based memantine extended release (ER) treatment in children with autism spectrum disorder. MEM-MD-91, a 50-week open-label trial, identified memantine extended-release treatment responders for enrollment into M...

Descripción completa

Detalles Bibliográficos
Autores principales: Hardan, Antonio Y, Hendren, Robert L, Aman, Michael G, Robb, Adelaide, Melmed, Raun D, Andersen, Kristen A, Luchini, Rachel, Rahman, Rezwanur, Ali, Sanjida, Jia, X Daniel, Mallick, Madhuja, Lateiner, Jordan E, Palmer, Robert H, Graham, Stephen M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779018/
https://www.ncbi.nlm.nih.gov/pubmed/31027422
http://dx.doi.org/10.1177/1362361318824103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779018/
https://www.ncbi.nlm.nih.gov/pubmed/31027422
http://dx.doi.org/10.1177/1362361318824103

Ejemplares similares